Renal protection with antagonists of the angiotensin Ii receptors
Aranda, P.; Aranda F, J.
Medicina Clinica 114(Suppl 1): 29-33
2000
ISSN/ISBN: 0025-7753 PMID: 10812572 Document Number: 516052
Document emailed within 1 workday
Related Documents
Edwards, R.M.; Stack, E.J.; Weidley, E.F.; Aiyar, N.; Keenan, R.M.; Hill, D.T.; Weinstock, J. 1992: Characterization of renal angiotensin Ii receptors using subtype selective antagonists Journal of Pharmacology and Experimental Therapeutics 260(3): 933-938Jover, B.; Mimran, A. 1994: Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(9): S3-S9
Laudanno, O.M.; Cesolari, J.é A.M. 2006: Angiotensin Ii AT1 receptor antagonists as antiinflammatory and gastric protection drugs Acta Gastroenterologica Latinoamericana 36(2): 76-80
Dimitrov, Y.; Muller, S.; Hannedouche, T. 1997: Renal effects of AT1 angiotensin receptor antagonists (AT1ra) Presse Medicale 26(40): 1981-1986
Epstein, M. 1998: Calcium antagonists and renal protection: emerging perspectives Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 16(4): S17-S25
Epstein, M. 1992: Calcium antagonists and renal protection. Current status and future perspectives Archives of Internal Medicine 152(8): 1573-1584
Ménard, J. 1993: Anthology of the renin-angiotensin system: a one hundred reference approach to angiotensin II antagonists Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 11(3): S3-11
De Paz, S.; Martín, A.B.; Iglesias, A.; Domínguez, A.R. 1999: Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin Ii receptor antagonists Medicina Clinica 113(19): 759
Wong, P.C.; Timmermans, P.B. 1991: Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753 Journal of Pharmacology and Experimental Therapeutics 258(1): 49-57
Schreiber, R.; Brocco, M.; Audinot, V.; Gobert, A.; Veiga, S.; Millan, M.J. 1995: (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists Journal of Pharmacology and Experimental Therapeutics 273(1): 101-112
Renke, M.; Rutkowski, Pław.; Tylicki, L.; Zietkiewicz, M.; Larczyński, W.; Rutkowski, Bław. 2008: Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline Przeglad Lekarski 65(6): 312-314
Robberecht, P.; Gourlet, P. 1996: Recombinant receptors for testing agonists and antagonists of VIP and PACAP receptors Journal de Pharmacie de Belgique 51(3): 165-169
Qadri, F.; Culman, J.; Veltmar, A.; Maas, K.; Rascher, W.; Unger, T. 1993: Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin Ii AT1 receptors in the supraoptic nucleus Journal of Pharmacology and Experimental Therapeutics 267(2): 567-574
Wemer, J.; van der Lugt, J.C.; de Langen, C.D.; Mulder, A.H. 1979: On the capacity of presynaptic alpha receptors to modulate norepinephrine release from slices of rat neocortex and the affinity of some agonists and antagonists for these receptors Journal of Pharmacology and Experimental Therapeutics 211(3): 445-451
Raiden, S.; Giordano, M.; Andonegui, G.; Trevani, A.S.; López, D.H.; Nahmod, V.; Geffner, J.R. 1997: Losartan, a selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits the binding of N-formylmethionyl-leucyl-phenylalanine to neutrophil receptors Journal of Pharmacology and Experimental Therapeutics 281(2): 624-628
Ferreira-do-Vale, C.; Renzi, A.; Camargo, G.P.; Saad, W.A.; Luiz, A.C.; Menani, J.V.; Silveira, J.E.; Camargo, L.A. 1995: The role of angiotensin AT1 receptors in the diuretic, natriuretic, kaliuretic and blood pressure responses induced by angiotensin II activation of the median preoptic nucleus in conscious rats Brazilian Journal of Medical and Biological Research 28(10): 1097-1101
Lijnen, P.J.; Fagard, R.H.; Amery, A.K. 1979: Effects of angiotensin Ii and 1-Sar-8-Ala-angiotensin Ii on the renal function in sodium-replete and -deplete dogs Archives Internationales de Physiologie et de Biochimie 87(1): 193-194
Bornkessel, B. 1995: Angiotensin Ii receptor antagonists Medizinische Monatsschrift für Pharmazeuten 18(6): 148-151
Chung, O.; Unger, T. 1996: Angiotensin Ii receptor antagonists Der Internist 37(5): 534-538; Discussion 538
Zou, L.X.; Hymel, A.; Imig, J.D.; Navar, L.G. 1996: Renal accumulation of circulating angiotensin II in angiotensin II-infused rats Hypertension 27(3 Pt 2): 658-662